Title
Statements
Body
2025
DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access - January 17, 2025
2024
DEA and HHS Extend Telemedicine Flexibilities through 2025 - November 15, 2024
2021
Statement on 42 CFR Part 2 Amendments Process - April 9, 2021
Last Updated
Last Updated: 01/20/2025